Trial Outcomes & Findings for BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal (NCT NCT03367247)
NCT ID: NCT03367247
Last Updated: 2026-03-10
Results Overview
≥50% consent-to-approach ratio
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
121 participants
Primary outcome timeframe
1 month
Results posted on
2026-03-10
Participant Flow
Participant milestones
| Measure |
Phase Ia: 10-week Pre-pilot Patients
In this single arm pre-pilot, patients and caregiver dyads were offered a total of 12 contacts with a BOLSTER study nurse over 10 weeks and daily contact via a smartphone-based symptom app which queries patients about their symptoms using questions from the PRO-CTCAE, risk-stratifies their symptoms, and provides tailored symptom management advice. Participants also had access to web-based symptom management and medical skills training.
|
Phase Ia: 10-week Pre-pilot Caregivers
In this single arm pre-pilot, patients and caregiver dyads were offered a total of 12 contacts with a BOLSTER study nurse over 10 weeks and daily contact via a smartphone-based symptom app which queries patients about their symptoms using questions from the PRO-CTCAE, risk-stratifies their symptoms, and provides tailored symptom management advice. Participants also had access to web-based symptom management and medical skills training.
|
Phase Ib: 4-week Pre-pilot Patients
The second, abbreviated iteration of the intervention consisted of a single arm pre-pilot, in which patient and caregiver dyads were offered a total of 6 contacts with a BOLSTER study nurse over 4 weeks and daily contact via a smartphone-based symptom app which queries patients about their symptoms using questions from the PRO-CTCAE, risk-stratifies their symptoms, and provides tailored symptom management advice. Participants also had access to web-based symptom management and medical skills training.
|
Phase Ib: 4-week Pre-pilot Caregivers
The second, abbreviated iteration of the intervention consisted of a single arm pre-pilot, in which patient and caregiver dyads were offered a total of 6 contacts with a BOLSTER study nurse over 4 weeks and daily contact via a smartphone-based symptom app which queries patients about their symptoms using questions from the PRO-CTCAE, risk-stratifies their symptoms, and provides tailored symptom management advice. Participants also had access to web-based symptom management and medical skills training.
|
Phase II (RCT): BOLSTER Arm Patients
BOLSTER provides participants with longitudinal nursing support across care settings, a smartphone-based symptom management app, a print and web-based symptom management toolkit, and advance care planning to ensure that the patient receives care that is congruent with her informed preferences. BOLSTER includes a total of 6 contacts with a study nurse over 4 weeks. Daily contact via a smartphone-based symptom app which queries patients about their symptoms using questions from the PRO-CTCAE, risk-stratifies their symptoms, and provides tailored symptom management advice.
|
Phase II (RCT): BOLSTER Arm Caregivers
BOLSTER provides participants with longitudinal nursing support across care settings, a smartphone-based symptom management app, a print and web-based symptom management toolkit, and advance care planning to ensure that the patient receives care that is congruent with her informed preferences. BOLSTER includes a total of 6 contacts with a study nurse over 4 weeks. Daily contact via a smartphone-based symptom app which queries patients about their symptoms using questions from the PRO-CTCAE, risk-stratifies their symptoms, and provides tailored symptom management advice.
|
Phase II (RCT): EDP Arm Patients
Enhanced Discharge Planning (EDP): EDP provides patients and caregivers a single session of education and skills training, symptom management, and support. The EDP participants received medication education, self-management strategies for symptoms, skills training, and a list of red flag symptoms and numbers for who to call.
|
Phase II (RCT): EDP Arm Caregivers
Enhanced Discharge Planning (EDP): EDP provides patients and caregivers a single session of education and skills training, symptom management, and support. The EDP participants received medication education, self-management strategies for symptoms, skills training, and a list of red flag symptoms and numbers for who to call.
|
|---|---|---|---|---|---|---|---|---|
|
Overall Study
STARTED
|
6
|
6
|
5
|
4
|
29
|
17
|
32
|
22
|
|
Overall Study
COMPLETED
|
3
|
3
|
5
|
4
|
21
|
11
|
20
|
15
|
|
Overall Study
NOT COMPLETED
|
3
|
3
|
0
|
0
|
8
|
6
|
12
|
7
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal
Baseline characteristics by cohort
| Measure |
Phase Ia: 10-week Pre-pilot Patients
n=6 Participants
In this single arm pre-pilot, patients and caregiver dyads were offered a total of 12 contacts with a BOLSTER study nurse over 10 weeks and daily contact via a smartphone-based symptom app which queries patients about their symptoms using questions from the PRO-CTCAE, risk-stratifies their symptoms, and provides tailored symptom management advice. Participants also had access to web-based symptom management and medical skills training.
|
Phase Ia: 10-week Pre-pilot Caregivers
n=6 Participants
In this single arm pre-pilot, patients and caregiver dyads were offered a total of 12 contacts with a BOLSTER study nurse over 10 weeks and daily contact via a smartphone-based symptom app which queries patients about their symptoms using questions from the PRO-CTCAE, risk-stratifies their symptoms, and provides tailored symptom management advice. Participants also had access to web-based symptom management and medical skills training.
|
Phase Ib: 4-week Pre-pilot Patients
n=5 Participants
The second, abbreviated iteration of the intervention consisted of a single arm pre-pilot, in which patient and caregiver dyads were offered a total of 6 contacts with a BOLSTER study nurse over 4 weeks and daily contact via a smartphone-based symptom app which queries patients about their symptoms using questions from the PRO-CTCAE, risk-stratifies their symptoms, and provides tailored symptom management advice. Participants also had access to web-based symptom management and medical skills training.
|
Phase Ib: 4-week Pre-pilot Caregivers
n=4 Participants
The second, abbreviated iteration of the intervention consisted of a single arm pre-pilot, in which patient and caregiver dyads were offered a total of 6 contacts with a BOLSTER study nurse over 4 weeks and daily contact via a smartphone-based symptom app which queries patients about their symptoms using questions from the PRO-CTCAE, risk-stratifies their symptoms, and provides tailored symptom management advice. Participants also had access to web-based symptom management and medical skills training.
|
Phase II (RCT): BOLSTER Arm Patients
n=29 Participants
BOLSTER provides participants with longitudinal nursing support across care settings, a smartphone-based symptom management app, a print and web-based symptom management toolkit, and advance care planning to ensure that the patient receives care that is congruent with her informed preferences. BOLSTER includes a total of 6 contacts with a study nurse over 4 weeks. Daily contact via a smartphone-based symptom app which queries patients about their symptoms using questions from the PRO-CTCAE, risk-stratifies their symptoms, and provides tailored symptom management advice.
|
Phase II (RCT): BOLSTER Arm Caregivers
n=17 Participants
BOLSTER provides participants with longitudinal nursing support across care settings, a smartphone-based symptom management app, a print and web-based symptom management toolkit, and advance care planning to ensure that the patient receives care that is congruent with her informed preferences. BOLSTER includes a total of 6 contacts with a study nurse over 4 weeks. Daily contact via a smartphone-based symptom app which queries patients about their symptoms using questions from the PRO-CTCAE, risk-stratifies their symptoms, and provides tailored symptom management advice.
|
Phase II (RCT): EDP Arm Patients
n=32 Participants
Enhanced Discharge Planning (EDP): EDP provides patients and caregivers a single session of education and skills training, symptom management, and support. The EDP participants received medication education, self-management strategies for symptoms, skills training, and a list of red flag symptoms and numbers for who to call.
|
Phase II (RCT): EDP Arm Caregivers
n=22 Participants
Enhanced Discharge Planning (EDP): EDP provides patients and caregivers a single session of education and skills training, symptom management, and support. The EDP participants received medication education, self-management strategies for symptoms, skills training, and a list of red flag symptoms and numbers for who to call.
|
Total
n=121 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|---|---|---|
|
Age, Continuous
|
64 years
STANDARD_DEVIATION 7.31 • n=68 Participants
|
64 years
STANDARD_DEVIATION 6.63 • n=69 Participants
|
58 years
STANDARD_DEVIATION 14.03 • n=137 Participants
|
62 years
STANDARD_DEVIATION 12.48 • n=88 Participants
|
60 years
STANDARD_DEVIATION 10.17 • n=127 Participants
|
59 years
STANDARD_DEVIATION 9.54 • n=605 Participants
|
62 years
STANDARD_DEVIATION 7.51 • n=9 Participants
|
60 years
STANDARD_DEVIATION 10.21 • n=72 Participants
|
61 years
STANDARD_DEVIATION 9.46 • n=6 Participants
|
|
Sex: Female, Male
Female
|
6 Participants
n=68 Participants
|
1 Participants
n=69 Participants
|
5 Participants
n=137 Participants
|
1 Participants
n=88 Participants
|
25 Participants
n=127 Participants
|
10 Participants
n=605 Participants
|
31 Participants
n=9 Participants
|
7 Participants
n=72 Participants
|
86 Participants
n=6 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=68 Participants
|
5 Participants
n=69 Participants
|
0 Participants
n=137 Participants
|
3 Participants
n=88 Participants
|
4 Participants
n=127 Participants
|
7 Participants
n=605 Participants
|
1 Participants
n=9 Participants
|
15 Participants
n=72 Participants
|
35 Participants
n=6 Participants
|
|
Race/Ethnicity, Customized
American Indian or Alaska Native
|
0 Participants
n=68 Participants
|
0 Participants
n=69 Participants
|
0 Participants
n=137 Participants
|
0 Participants
n=88 Participants
|
0 Participants
n=127 Participants
|
0 Participants
n=605 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=72 Participants
|
0 Participants
n=6 Participants
|
|
Race/Ethnicity, Customized
Asian
|
0 Participants
n=68 Participants
|
0 Participants
n=69 Participants
|
1 Participants
n=137 Participants
|
1 Participants
n=88 Participants
|
2 Participants
n=127 Participants
|
1 Participants
n=605 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=72 Participants
|
5 Participants
n=6 Participants
|
|
Race/Ethnicity, Customized
Black or African American
|
0 Participants
n=68 Participants
|
0 Participants
n=69 Participants
|
0 Participants
n=137 Participants
|
0 Participants
n=88 Participants
|
0 Participants
n=127 Participants
|
0 Participants
n=605 Participants
|
3 Participants
n=9 Participants
|
2 Participants
n=72 Participants
|
5 Participants
n=6 Participants
|
|
Race/Ethnicity, Customized
Native Hawaiian or Pacific Islander
|
0 Participants
n=68 Participants
|
0 Participants
n=69 Participants
|
0 Participants
n=137 Participants
|
0 Participants
n=88 Participants
|
1 Participants
n=127 Participants
|
1 Participants
n=605 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=72 Participants
|
2 Participants
n=6 Participants
|
|
Race/Ethnicity, Customized
White
|
6 Participants
n=68 Participants
|
6 Participants
n=69 Participants
|
4 Participants
n=137 Participants
|
3 Participants
n=88 Participants
|
24 Participants
n=127 Participants
|
14 Participants
n=605 Participants
|
26 Participants
n=9 Participants
|
20 Participants
n=72 Participants
|
103 Participants
n=6 Participants
|
|
Race/Ethnicity, Customized
Other
|
0 Participants
n=68 Participants
|
0 Participants
n=69 Participants
|
0 Participants
n=137 Participants
|
0 Participants
n=88 Participants
|
1 Participants
n=127 Participants
|
0 Participants
n=605 Participants
|
3 Participants
n=9 Participants
|
0 Participants
n=72 Participants
|
4 Participants
n=6 Participants
|
|
Race/Ethnicity, Customized
I don't know/refuse to answer
|
0 Participants
n=68 Participants
|
0 Participants
n=69 Participants
|
0 Participants
n=137 Participants
|
0 Participants
n=88 Participants
|
1 Participants
n=127 Participants
|
1 Participants
n=605 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=72 Participants
|
2 Participants
n=6 Participants
|
|
Ethnicity
Hispanic or LatinX
|
0 Participants
n=68 Participants
|
0 Participants
n=69 Participants
|
0 Participants
n=137 Participants
|
0 Participants
n=88 Participants
|
1 Participants
n=127 Participants
|
0 Participants
n=605 Participants
|
2 Participants
n=9 Participants
|
1 Participants
n=72 Participants
|
4 Participants
n=6 Participants
|
|
Ethnicity
Not Hispanic or LatinX
|
6 Participants
n=68 Participants
|
6 Participants
n=69 Participants
|
5 Participants
n=137 Participants
|
4 Participants
n=88 Participants
|
27 Participants
n=127 Participants
|
16 Participants
n=605 Participants
|
27 Participants
n=9 Participants
|
21 Participants
n=72 Participants
|
112 Participants
n=6 Participants
|
|
Ethnicity
Missing
|
0 Participants
n=68 Participants
|
0 Participants
n=69 Participants
|
0 Participants
n=137 Participants
|
0 Participants
n=88 Participants
|
1 Participants
n=127 Participants
|
1 Participants
n=605 Participants
|
3 Participants
n=9 Participants
|
0 Participants
n=72 Participants
|
5 Participants
n=6 Participants
|
|
Marital Status
Married
|
5 Participants
n=68 Participants
|
6 Participants
n=69 Participants
|
5 Participants
n=137 Participants
|
4 Participants
n=88 Participants
|
22 Participants
n=127 Participants
|
16 Participants
n=605 Participants
|
26 Participants
n=9 Participants
|
20 Participants
n=72 Participants
|
104 Participants
n=6 Participants
|
|
Marital Status
Divorced/Separated
|
0 Participants
n=68 Participants
|
0 Participants
n=69 Participants
|
0 Participants
n=137 Participants
|
0 Participants
n=88 Participants
|
2 Participants
n=127 Participants
|
0 Participants
n=605 Participants
|
2 Participants
n=9 Participants
|
2 Participants
n=72 Participants
|
6 Participants
n=6 Participants
|
|
Marital Status
Single, never married
|
1 Participants
n=68 Participants
|
0 Participants
n=69 Participants
|
0 Participants
n=137 Participants
|
0 Participants
n=88 Participants
|
2 Participants
n=127 Participants
|
0 Participants
n=605 Participants
|
2 Participants
n=9 Participants
|
0 Participants
n=72 Participants
|
5 Participants
n=6 Participants
|
|
Marital Status
Widowed
|
0 Participants
n=68 Participants
|
0 Participants
n=69 Participants
|
0 Participants
n=137 Participants
|
0 Participants
n=88 Participants
|
1 Participants
n=127 Participants
|
0 Participants
n=605 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=72 Participants
|
1 Participants
n=6 Participants
|
|
Marital Status
Partnered
|
0 Participants
n=68 Participants
|
0 Participants
n=69 Participants
|
0 Participants
n=137 Participants
|
0 Participants
n=88 Participants
|
1 Participants
n=127 Participants
|
1 Participants
n=605 Participants
|
1 Participants
n=9 Participants
|
0 Participants
n=72 Participants
|
3 Participants
n=6 Participants
|
|
Marital Status
I don't know/refused
|
0 Participants
n=68 Participants
|
0 Participants
n=69 Participants
|
0 Participants
n=137 Participants
|
0 Participants
n=88 Participants
|
1 Participants
n=127 Participants
|
0 Participants
n=605 Participants
|
1 Participants
n=9 Participants
|
0 Participants
n=72 Participants
|
2 Participants
n=6 Participants
|
|
Highest Level of Education
8th grade or less
|
0 Participants
n=68 Participants
|
0 Participants
n=69 Participants
|
0 Participants
n=137 Participants
|
0 Participants
n=88 Participants
|
0 Participants
n=127 Participants
|
0 Participants
n=605 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=72 Participants
|
0 Participants
n=6 Participants
|
|
Highest Level of Education
9 - 11th grade
|
0 Participants
n=68 Participants
|
0 Participants
n=69 Participants
|
1 Participants
n=137 Participants
|
0 Participants
n=88 Participants
|
0 Participants
n=127 Participants
|
0 Participants
n=605 Participants
|
1 Participants
n=9 Participants
|
0 Participants
n=72 Participants
|
2 Participants
n=6 Participants
|
|
Highest Level of Education
High school graduate / GED
|
1 Participants
n=68 Participants
|
2 Participants
n=69 Participants
|
0 Participants
n=137 Participants
|
1 Participants
n=88 Participants
|
1 Participants
n=127 Participants
|
2 Participants
n=605 Participants
|
3 Participants
n=9 Participants
|
1 Participants
n=72 Participants
|
11 Participants
n=6 Participants
|
|
Highest Level of Education
Vocational / Technical training
|
0 Participants
n=68 Participants
|
0 Participants
n=69 Participants
|
0 Participants
n=137 Participants
|
0 Participants
n=88 Participants
|
1 Participants
n=127 Participants
|
0 Participants
n=605 Participants
|
0 Participants
n=9 Participants
|
3 Participants
n=72 Participants
|
4 Participants
n=6 Participants
|
|
Highest Level of Education
Associate degree / some college
|
0 Participants
n=68 Participants
|
0 Participants
n=69 Participants
|
1 Participants
n=137 Participants
|
0 Participants
n=88 Participants
|
1 Participants
n=127 Participants
|
1 Participants
n=605 Participants
|
2 Participants
n=9 Participants
|
3 Participants
n=72 Participants
|
8 Participants
n=6 Participants
|
|
Highest Level of Education
Bachelor's degree
|
2 Participants
n=68 Participants
|
1 Participants
n=69 Participants
|
3 Participants
n=137 Participants
|
2 Participants
n=88 Participants
|
11 Participants
n=127 Participants
|
3 Participants
n=605 Participants
|
11 Participants
n=9 Participants
|
8 Participants
n=72 Participants
|
41 Participants
n=6 Participants
|
|
Highest Level of Education
Advanced degree
|
2 Participants
n=68 Participants
|
3 Participants
n=69 Participants
|
0 Participants
n=137 Participants
|
1 Participants
n=88 Participants
|
14 Participants
n=127 Participants
|
11 Participants
n=605 Participants
|
14 Participants
n=9 Participants
|
7 Participants
n=72 Participants
|
52 Participants
n=6 Participants
|
|
Highest Level of Education
Refuse to answer
|
1 Participants
n=68 Participants
|
0 Participants
n=69 Participants
|
0 Participants
n=137 Participants
|
0 Participants
n=88 Participants
|
1 Participants
n=127 Participants
|
0 Participants
n=605 Participants
|
1 Participants
n=9 Participants
|
0 Participants
n=72 Participants
|
3 Participants
n=6 Participants
|
PRIMARY outcome
Timeframe: 1 month≥50% consent-to-approach ratio
Outcome measures
| Measure |
Patients Approached
n=95 Participants
The number of patients that study staff approached regarding participation in the study
|
Phase II (RCT): BOLSTER Arm Caregivers
BOLSTER provides participants with longitudinal nursing support across care settings, a smartphone-based symptom management app, a print and web-based symptom management toolkit, and advance care planning to ensure that the patient receives care that is congruent with her informed preferences. BOLSTER includes a total of 6 contacts with a study nurse over 4 weeks. Daily contact via a smartphone-based symptom app which queries patients about their symptoms using questions from the PRO-CTCAE, risk-stratifies their symptoms, and provides tailored symptom management advice.
|
|---|---|---|
|
Feasibility of the BOLSTER Intervention
Consented
|
73 Participants
|
—
|
|
Feasibility of the BOLSTER Intervention
Did not consent
|
22 Participants
|
—
|
SECONDARY outcome
Timeframe: 3 months≥70% participants "agree" or "strongly agree" that they would recommend BOLSTER to other patients; and ≥70% participants "agreed or "strongly agreed" that they were satisfied with the BOLSTER intervention. Note that this measure only includes data from the RCT portion of the study, as the Phases 1a and 1b were designed to refine the intervention.
Outcome measures
| Measure |
Patients Approached
n=22 Participants
The number of patients that study staff approached regarding participation in the study
|
Phase II (RCT): BOLSTER Arm Caregivers
n=10 Participants
BOLSTER provides participants with longitudinal nursing support across care settings, a smartphone-based symptom management app, a print and web-based symptom management toolkit, and advance care planning to ensure that the patient receives care that is congruent with her informed preferences. BOLSTER includes a total of 6 contacts with a study nurse over 4 weeks. Daily contact via a smartphone-based symptom app which queries patients about their symptoms using questions from the PRO-CTCAE, risk-stratifies their symptoms, and provides tailored symptom management advice.
|
|---|---|---|
|
Acceptability of the BOLSTER Intervention
Acceptability - "I have been satisfied with the BOLSTER program sessions..." · Strongly agree
|
14 Participants
|
8 Participants
|
|
Acceptability of the BOLSTER Intervention
Acceptability - "I have been satisfied with the BOLSTER program sessions..." · Agree
|
6 Participants
|
2 Participants
|
|
Acceptability of the BOLSTER Intervention
Acceptability - "I have been satisfied with the BOLSTER program sessions..." · Neither agree nor disagree
|
2 Participants
|
0 Participants
|
|
Acceptability of the BOLSTER Intervention
Acceptability - "I would recommend the BOLSTER program to other patients..." · Strongly agree
|
16 Participants
|
8 Participants
|
|
Acceptability of the BOLSTER Intervention
Acceptability - "I would recommend the BOLSTER program to other patients..." · Agree
|
5 Participants
|
2 Participants
|
|
Acceptability of the BOLSTER Intervention
Acceptability - "I would recommend the BOLSTER program to other patients..." · Neither agree nor disagree
|
1 Participants
|
0 Participants
|
Adverse Events
Phase Ia: 10-week Pre-pilot Patients
Serious events: 0 serious events
Other events: 0 other events
Deaths: 3 deaths
Phase Ia: 10-week Pre-pilot Caregivers
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Phase Ib: 4-week Pre-pilot Patients
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Phase Ib: 4-week Pre-pilot Caregivers
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Phase II (RCT): BOLSTER Arm Patients
Serious events: 0 serious events
Other events: 0 other events
Deaths: 5 deaths
Phase II (RCT): BOLSTER Arm Caregivers
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Phase II (RCT): EDP Arm Patients
Serious events: 0 serious events
Other events: 0 other events
Deaths: 3 deaths
Phase II (RCT): EDP Arm Caregivers
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place